Locations
North America · Cambridge, MA, USA · Cambridge, MA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series C+
founded in
2021
Odyssey Therapeutics is a clinical-stage biopharmaceutical company focused on transforming the standard of care for patients with autoimmune and inflammatory diseases. The company develops medicines that precisely target disease pathology, leveraging a deep understanding of immunobiology and a robust pipeline of small molecule and protein therapeutics. Their innovative approach aims to prevent pathological inflammation by targeting upstream signaling nodes in the immune system, which differentiates them from existing therapies that only address downstream effects. With a commitment to addressing significant unmet needs in large patient populations, Odyssey is positioned to make a meaningful impact in the treatment of inflammatory diseases.
Something looks off?On-site & Remote